Q4 2025 Earnings Summary
Metric | YoY Change | Reason |
---|---|---|
Total Revenue Q3 2024 | Increased from $218.3M to $228.8M | Revenue rose by roughly 4.7% driven by core revenue growth of over 6%, with the Food Safety segment advancing 4% to $157.8M and the Animal Safety segment growing 7% to $71M, bolstered by strong performance in Petrifilm and sample handling products—even as shipping inefficiencies and integration challenges created some operational pressure. |
Total Revenue Q3 2025 | Decreased from $228.8M to $221M, about -3.4% | The decline was chiefly due to a 3.1% drop from foreign currency impacts compounded by a 3.2% decline in Food Safety revenue to $153M and a 2.6% drop in Animal Safety revenue to $68M, accentuated further by softer macroeconomic conditions and shipping delays observed across key regions. |
Total Revenue Q4 2025 | Increased 2% QoQ from $220.98M to $225.5M | Q4 2025 showed a modest 2% recovery compared to Q3 2025, suggesting a partial rebound possibly from improved operational performance and market stabilization; however, without segment-level details, the specific drivers relative to previous periods remain less quantifiable. |
Metric | Period | Guidance | Actual | Performance |
---|---|---|---|---|
Revenue | FY 2025 | ~$895 million | ~$894.70 million (sum of Q1: 216.964, Q2: 231.258, Q3: 220.98, Q4: 225.5) | Met |
Research analysts covering NEOGEN.